COVID-19 testing

Covenant Health and Urgent Care Group Now Offer Urgent Care in South Knoxville

Retrieved on: 
Tuesday, October 17, 2023
Nursing, Health, Hospitals, Physical Therapy, Managed Care, General Health, Pharmaceutical, Partnership, COVID-19, Physician, Covenant, Total Access Communication System, Cardiology, CHUC, Northside Hospital, UCG, COVID-19 testing, Patient, Rehabilitation, Covenant Health, Volunteering, Occupational Safety and Health Act 1994, Suite, Hospital

Covenant Health and Urgent Care Group (UCG) are pleased to announce the opening of the first Covenant Health Urgent Care in South Knoxville.

Key Points: 
  • Covenant Health and Urgent Care Group (UCG) are pleased to announce the opening of the first Covenant Health Urgent Care in South Knoxville.
  • Covenant Health Urgent Care is located in Covenant Health South , a newly constructed, free-standing medical facility in South Knoxville , located at the corner of Chapman Highway and Mountain Grove Drive at 7625 Chapman Highway, Suite 107, Knoxville, TN 37920.
  • In addition to urgent care, the Covenant Health South campus includes primary care, cardiology, women’s health, imaging, rehabilitation, and other specialties.
  • With the addition of the Covenant Health partnership, the UCG network now includes 57 centers operating as six brands: Covenant Health Urgent Care in East Tennessee, Health Choice Urgent Care in partnership with Northside Hospital in Georgia, Medac Urgent Care in North Carolina, MEDcare Urgent Care in South Carolina, ParkMed Urgent Care in Tennessee, and Total Access Urgent Care in Missouri.

ixlayer Expands Clinical Advisory Board with the Appointment of Walgreens Chief Medical Officer Kevin Ban

Retrieved on: 
Tuesday, October 17, 2023
Athenahealth, Health, COVID-19, Vaccination, Growth, Walgreens, Pharmacist, Walgreens Boots Alliance, COVID-19 testing, SAN, Nursing, Pharmaceutical industry

SAN FRANCISCO, Oct. 17, 2023 /PRNewswire/ -- ixlayer, the leading provider of cloud-based platforms empowering diagnostic testing for greater operational efficiency, patient access, and improved outcomes today announced it is expanding its clinical advisory board with the addition of Kevin Ban, M.D.

Key Points: 
  • SAN FRANCISCO, Oct. 17, 2023 /PRNewswire/ -- ixlayer, the leading provider of cloud-based platforms empowering diagnostic testing for greater operational efficiency, patient access, and improved outcomes today announced it is expanding its clinical advisory board with the addition of Kevin Ban, M.D.
  • Dr. Ban is Executive Vice President and Global Chief Medical Officer for Walgreens Boots Alliance, where he played a critical role in leading the company's national pandemic response.
  • I'm excited to work with ixlayer and the company's entire advisory team in developing new solutions and programs that help move the lab testing industry forward," said Dr. Ban.
  • Previously, he served as Chief Medical Officer at Athenahealth and Beth Israel Deaconess Needham.

On/Go Named 2023 Fierce 50 Social Impact Honoree For Its Charitable Work Via On/Go for Good

Retrieved on: 
Friday, October 6, 2023
Health, COVID-19, Hospital, Make-A-Wish Foundation, American Diabetes Association, Fierce, Organization, Population health, COVID-19 testing, Entrepreneurship, Mental health, Good, Education, The Co Founder, Software, GO Campaign, Social impact, Computer, Nursing, San Francisco Bay Area

Fierce 50 recognizes individuals and organizations that confront pressing health challenges, fostering awareness and education while implementing interventions that have a profound impact on the fabric of health and well-being.

Key Points: 
  • Fierce 50 recognizes individuals and organizations that confront pressing health challenges, fostering awareness and education while implementing interventions that have a profound impact on the fabric of health and well-being.
  • The group of 50 has been honored for leading the charge on crucial social issues.
  • The approach of "doing good by doing well" has benefitted hundreds of millions of people globally.
  • When good people are sometimes unsure and hesitant about how to make a difference - we're inclined to a rapid action-learning-iterations cycle that results in real impact.

Peer-Reviewed Independent Study Published in Microbiology Spectrum Finds Cue Health’s Molecular COVID-19 Test is as Accurate as a Lab-Based PCR Test

Retrieved on: 
Wednesday, October 4, 2023
Biotechnology, Health, COVID-19, Clinical Trials, Infection, Microbiology, De novo, RNS, Landing slot, ISO, American Society for Microbiology, RT-PCR, FH, COVID-19 testing, Trial of the century, Viral load, Immunodeficiency, FDA, RT, Health Canada, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Society, Cue, PCR, Food, Pharmaceutical industry, Nursing, Vaccine, Microbiology Spectrum

The study, published in Microbiology Spectrum, a journal produced by the American Society for Microbiology, presents findings from a head-to-head comparison of the Cue COVID-19 test against lab-based RT-PCR on paired samples from 3,037 individuals.

Key Points: 
  • The study, published in Microbiology Spectrum, a journal produced by the American Society for Microbiology, presents findings from a head-to-head comparison of the Cue COVID-19 test against lab-based RT-PCR on paired samples from 3,037 individuals.
  • The findings from paired testing revealed a 99.4% match between results from Cue’s test and the reference PCR tests with 100% clinical sensitivity to detect positive cases, yielding no false negatives.
  • To further expand its diagnostic test menu for at-home and point-of-care use, Cue has made a number of other submissions with the FDA.
  • Cue did not provide funding or any other support of the study.

Virtual Asthma Coaching Found to Improve Asthma Control

Retrieved on: 
Tuesday, October 3, 2023
Amgen, Partnership, Asthma, Network, Education, Hospital, Regeneron Pharmaceuticals, Health, Dermatitis, Native, COVID-19, Food, Health equity, Quality of life, Human, Allergy, AstraZeneca, COVID-19 testing, Messenger, Novartis, Risk, Disease, Sanofi, Mortality, Death, Pharmaceutical industry, Genentech

FAIRFAX, Va., Oct. 3, 2023 /PRNewswire/ -- Adults with uncontrolled asthma who take part in virtual asthma coaching show improved asthma control and quality of life, and experience fewer doctor or emergency department visits. Those are the key findings of a new impact report summarizing Allergy & Asthma Network's innovative Virtual Asthma Coaching program.

Key Points: 
  • Those are the key findings of a new impact report summarizing Allergy & Asthma Network's innovative Virtual Asthma Coaching program.
  • The Virtual Asthma Coaching program is part of Trusted Messengers, Allergy & Asthma Network's largest health equity initiative.
  • "Our Virtual Asthma Coaching program saves lives," says Lynda Mitchell, CEO of Allergy & Asthma Network.
  • The Virtual Asthma Coaching program began in 2020 as a pilot program during Allergy & Asthma Network's response to the COVID-19 pandemic.

EQS-News: Cinven to launch public acquisition offer for SYNLAB AG

Retrieved on: 
Friday, September 29, 2023
Financial Oversight and Management Board for Puerto Rico, SMBC, Goldman, Banco Santander, Frankfurt Stock Exchange, COVID-19, Clifford Chance, Supervisory board, XETRA, Ontario Teachers' Pension Plan, BNP Paribas, Deutsche Bank, COVID-19 testing, Qatar Investment Authority, Macquarie Group, Physikalisch-Technische Bundesanstalt, Goldman Sachs, Citigroup, BSAC London Branch, Raiffeisen Bank International, EBITDA, Federal Financial Supervisory Authority, HSBC Continental Europe, Novo Holdings A/S, EUR, Acquisition, UniCredit, Swanson v. Citibank N.A., ING Group, Standard Chartered, Citibank, PCR, Barclays, 2021 German federal election, Security (finance), Life insurance, Cinven

(“Ephios”), an entity controlled by funds managed and/or advised by Cinven, today announced its decision to launch a public acquisition offer (the “Offer”) for all outstanding shares of SYNLAB AG (“SYNLAB” or the “Company”) not directly held by it.

Key Points: 
  • (“Ephios”), an entity controlled by funds managed and/or advised by Cinven, today announced its decision to launch a public acquisition offer (the “Offer”) for all outstanding shares of SYNLAB AG (“SYNLAB” or the “Company”) not directly held by it.
  • Cinven has not acquired any SYNLAB share from any shareholder above the offer price and does not intend to do so.
  • Cinven has secured financing commitments for the acquisition of all outstanding shares in SYNLAB AG not directly held by Ephios.
  • The offer document (once available) and other information relating to the Offer will be published on the following website: https://www.ephios-offer.com/

Global Nucleic Acid Isolation and Purification Market Trends Analysis Report 2023-2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 20, 2023
Medical Supplies, Biotechnology, Health, Pharmaceutical, Oncology, Other Science, Medical Devices, Infectious Diseases, Hospitals, Genetics, Science, Molecular biology, DNA, NGS, COVID-19, Cancer, Research, Infection, DSM-IV codes, RNA, USD, COVID-19 testing, Promega, Application, Medicine, Growth, Diagnosis, Fungal infection, Massive parallel sequencing, Automation, Fine chemical, Vaccine

The "Nucleic Acid Isolation And Purification Market Size, Share & Trends Analysis Report By Product, By Type, By Application, By Method, By End-use, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Nucleic Acid Isolation And Purification Market Size, Share & Trends Analysis Report By Product, By Type, By Application, By Method, By End-use, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global nucleic acid isolation and purification market size is expected to reach USD 11.21 billion by 2030, expanding at 10.06% CAGR from 2023 to 2030
    The global market for nucleic acid isolation and purification is poised for significant growth, driven by several key factors.
  • The COVID-19 pandemic has had a substantial impact on the demand for nucleic acid isolation and purification processes.
  • This heightened demand has underscored the importance of efficient nucleic acid isolation and purification techniques in the current healthcare landscape.

IDENTIFYSENSORS BIOLOGICS NAMES GLOBAL SALES DIRECTOR FOR NEW DIGITAL DIAGNOSTIC DEVICE PLATFORM

Retrieved on: 
Tuesday, September 12, 2023
Minnesota Center for Book Arts, DNA, University, Marketing, Policy, COVID-19, Diarrhea, MBA, RNA, COVID-19 testing, Sale, Center for Infectious Disease Research and Policy, Mathieson, Vertically transmitted infection, Research, Notre Dame, FDA, Management, Vaccine

CLEVELAND, Sept. 12, 2023 /PRNewswire/ -- IdentifySensors Biologics, a leading developer of digital diagnostic technologies, has named Mark Mathieson director of global sales operations.

Key Points: 
  • CLEVELAND, Sept. 12, 2023 /PRNewswire/ -- IdentifySensors Biologics, a leading developer of digital diagnostic technologies, has named Mark Mathieson director of global sales operations.
  • Mathieson joins the company with more than 20 years of experience launching, marketing and selling diagnostic systems for some of the largest brands in the world.
  • Devices for the new diagnostic platform began pilot production last month and will be used in clinical evaluations this fall.
  • This platform and its many elements are fully patented, and not yet approved for sale in the United States or other international markets.

Northside Hospital and Urgent Care Group Expand Urgent Care Access with New Center in Lawrenceville, GA

Retrieved on: 
Thursday, August 31, 2023
Hospitals, General Health, Health, Practice Management, Northside Hospital, Partnership, America's Affordable Health Choices Act of 2009, Urgent care center, Starbucks, COVID-19, COVID-19 testing, Occupational Safety and Health Act 1994, Patient, Growth, Hospital, Clatterbridge Health Park, Atlanta metropolitan area

Northside Hospital and Urgent Care Group are pleased to announce the opening of a new Health Choice Urgent Care center in Lawrenceville, Georgia.

Key Points: 
  • Northside Hospital and Urgent Care Group are pleased to announce the opening of a new Health Choice Urgent Care center in Lawrenceville, Georgia.
  • Health Choice Urgent Care is honored to have been voted Best of Gwinnett six years in a row.
  • “Urgent Care Group’s track record in the urgent care field is outstanding, and it fits well with Northside’s mission and patient care commitment.”
    Health Choice Urgent Care Lawrenceville opened August 30, 2023 and is located at 665 Duluth Highway, Lawrenceville, GA 30046.
  • Health Choice Urgent Care is delivering top-ranked patient care seven days per week from 8:00 am – 8:00 pm.

XWELL, Inc. Reports Second Quarter 2023 Results

Retrieved on: 
Monday, August 14, 2023
Partnership, Travel, John F. Kennedy International Airport, SARS-CoV-2, Public, Dubai International Airport, COVID-19, Airport, Foot, COVID-19 testing, Massage, CDC, The Company, Acquisition, CXM, Korea Disease Control and Prevention Agency, Webcast, CFO, Istanbul Airport, Growth, Health, Relaxation, Hydro massage, Rare-earth element, Video game, Pharmaceutical industry, Airline, Amusement park, Management, Vaccine

Second quarter 2023 revenue at the Company’s XpresSpa business increased approximately 59% versus the same quarter in 2022.

Key Points: 
  • Second quarter 2023 revenue at the Company’s XpresSpa business increased approximately 59% versus the same quarter in 2022.
  • Second quarter 2023 Operating Expenses decreased approximately 13% sequentially and decreased approximately 52% from the same quarter in 2022.
  • Total revenue during the second quarter ended June 30, 2023, was $8.2 million compared to $13.6 million in the prior year second quarter.
  • Cost of sales decreased to approximately $7.0 million for the second quarter of 2023 compared with approximately $12.4 million in the second quarter of 2022.